Na Yeon "Irene" Kim, MS, MBA
Ms. Kim is the Chief Executive Officer of E&Investment, Inc., a South Korean venture capital firm specializing in investments in life sciences companies, a position she has held since March 2018. From October 2015 until March 2018, Ms. Kim was a Representative Director for The SEED Investment Co., Ltd. (formerly known as OST Investment Co., Ltd.), a South Korean investment and fund manager specializing in investments in life sciences companies. From January 2015 until December 2017, Ms. Kim served as member of the board of directors of Macrogen, Inc., a South Korean, publicly-traded biotechnology company specializing in precision medicine and biotechnology. Ms. Kim focuses on investment opportunities in several industries, particularly in the field of biopharmaceuticals, and has more than 15 years of experience investing in private equity/venture capital markets. As an investor representative, Ms. Kim has successfully managed more than $400 million in private equity and venture capital funds.
Ms. Kim earned an M.S. and B.S. in biomolecular engineering, as well as an M.B.A. from Yonsei University in Korea.